Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Biocon
Sort By
Newest First
1 / 1
1 / 1
Biosimilars
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri®, Biosimilar Trastuzumab
Mylan
PR-M10-18-NI-071
Oct 22, 2018
Biosimilar
Mylan and Biocon Announce Positive CHMP Opinion for Fulphila®, Biosimilar Pegfilgrastim
Mylan
PR-M09-18-NI-087
Sep 27, 2018
Biosimilars
Sandoz - Biocon Deal One More Sign That U.S. Biosimilars Have Arrived
Kalorama Information
PR-M01-18-NI-086
Jan 26, 2018
Biosimilars
First Biosimilar to Treat Breast and Stomach Cancers Approved
Nice Insight
PAO-M12-17-NI-007
Dec 07, 2017
Biosimilar
FDA Recommends Approval of Trastuzumab Biosimilar
Guy Tiene
Nice Insight
PAO-M07-17-NI-025
Jul 21, 2017
